The long-term growth story for AstraZeneca PLC beyond 2030 is increasingly focused on next-generation cell therapies and ...

AstraZeneca PLC closed 0.08% below its 52-week high of £155.54, which the company achieved on February 24th.

Astrazeneca boss Pascal Soriot was handed his largest ever pay package last year - taking his total earnings at the pharma ...

Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects ...

AstraZeneca received FDA approval for Calquence with venetoclax, creating the first all oral, fixed duration regimen for ...

AstraZeneca has secured approval in the US for Calquence (acalabrutinib) plus venetoclax as the first all-oral, fixed-duration regimen to treat adults with chronic lymphocytic leu ...

Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by deploying Evinova’s artificial-intelligence-native ...

AstraZeneca has secured a key regulatory win in its effort to reclaim the lead in the BTK inhibitor market, with the FDA approving its combination of Calquence plus Venclexta as the first all-oral, ...

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space. The ...

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the message that the product frees chronic obstructive pulmonary disease (COPD) patients to leave their bad days ...

AstraZeneca Pharmaceuticals LP, for now, must abide by a Hawaii law that requires it to deliver discounted drugs to ...